カテゴリ： 世界, 医療/バイオ, QYResearch

インフルエンザ菌b型混合ワクチンの世界市場2023年：バイアル、プレフィルド

■ 英語タイトル：Global Haemophilus Influenzae Type b Conjugate Vaccine Market Research Report 2023

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA8781）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA8781
■ 発行日：2023年3月
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：87
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥435,000見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥652,500見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥870,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[インフルエンザ菌b型混合ワクチンの世界市場2023年：バイアル、プレフィルド]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

本調査資料はインフルエンザ菌b型混合ワクチンのグローバル市場について調査・分析し、世界のインフルエンザ菌b型混合ワクチン市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（バイアル、プレフィルド）、用途別セグメント分析（病院、地域医療サービスセンター、その他）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、Bharat Biotech、Glaxosmithkline、Biokangtai、Lanzhou Institute、Olymvax、Sanofi Pasteur、Walvax Biotechnology、Zhifei Biologicalなどが含まれています。インフルエンザ菌b型混合ワクチンのグローバル市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。新型コロナとロシア・ウクライナ戦争の影響は、インフルエンザ菌b型混合ワクチン市場規模を算出する際に考慮しました。

・インフルエンザ菌b型混合ワクチン市場の概要
- 製品の定義
- インフルエンザ菌b型混合ワクチンの種類別セグメント
- 世界のインフルエンザ菌b型混合ワクチン市場規模：タイプ別分析（バイアル、プレフィルド）
- インフルエンザ菌b型混合ワクチンの用途別セグメント
- 世界のインフルエンザ菌b型混合ワクチン市場規模：用途別分析（病院、地域医療サービスセンター、その他）
- 世界のインフルエンザ菌b型混合ワクチン市場規模予測（2018年-2029年）
- インフルエンザ菌b型混合ワクチンの平均価格推移（2018年-2029年）
- 前提条件と制限事項

・メーカー別競争状況
- メーカー別市場シェア
- 世界の主要メーカー、業界ランキング分析
- メーカー別平均価格
- インフルエンザ菌b型混合ワクチン市場の競争状況およびトレンド

・インフルエンザ菌b型混合ワクチンの地域別市場規模
- 北米のインフルエンザ菌b型混合ワクチン市場規模（2018年-2029年）
- 米国のインフルエンザ菌b型混合ワクチン市場規模（2018年-2029年）
- ヨーロッパのインフルエンザ菌b型混合ワクチン市場規模（2018年-2029年）
- アジア太平洋のインフルエンザ菌b型混合ワクチン市場規模（2018年-2029年）
- 中国のインフルエンザ菌b型混合ワクチン市場規模（2018年-2029年）
- 日本のインフルエンザ菌b型混合ワクチン市場規模（2018年-2029年）
- 韓国のインフルエンザ菌b型混合ワクチン市場規模（2018年-2029年）
- インドのインフルエンザ菌b型混合ワクチン市場規模（2018年-2029年）
- オーストラリアのインフルエンザ菌b型混合ワクチン市場規模（2018年-2029年）
- 中南米のインフルエンザ菌b型混合ワクチン市場規模（2018年-2029年）
- 中東・アフリカのインフルエンザ菌b型混合ワクチン市場規模（2018年-2029年）

・種類別セグメント：バイアル、プレフィルド
- 世界のインフルエンザ菌b型混合ワクチンのタイプ別販売量（2018年-2023年）
- 世界のインフルエンザ菌b型混合ワクチンのタイプ別売上（2018年-2023年）
- 世界のインフルエンザ菌b型混合ワクチンのタイプ別価格

・用途別セグメント：病院、地域医療サービスセンター、その他
- 世界のインフルエンザ菌b型混合ワクチンの用途別販売量（2018年-2023年）
- 世界のインフルエンザ菌b型混合ワクチンの用途別売上（2018年-2023年）
- 世界のインフルエンザ菌b型混合ワクチンの用途別価格

・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向
Bharat Biotech、Glaxosmithkline、Biokangtai、Lanzhou Institute、Olymvax、Sanofi Pasteur、Walvax Biotechnology、Zhifei Biological

・産業チェーンと販売チャネルの分析
- インフルエンザ菌b型混合ワクチン産業チェーン分析
- インフルエンザ菌b型混合ワクチンの主要原材料
- インフルエンザ菌b型混合ワクチンの販売チャネル
- インフルエンザ菌b型混合ワクチンのディストリビューター
- インフルエンザ菌b型混合ワクチンの主要顧客

・インフルエンザ菌b型混合ワクチン市場ダイナミクス
- インフルエンザ菌b型混合ワクチンの業界動向
- インフルエンザ菌b型混合ワクチン市場の成長ドライバ、課題、阻害要因

・調査の結論

・調査手法と情報源

Highlights
The global Haemophilus Influenzae Type b Conjugate Vaccine market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Haemophilus Influenzae Type b Conjugate Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Haemophilus Influenzae Type b Conjugate Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Haemophilus Influenzae Type b Conjugate Vaccine include Bharat Biotech, Glaxosmithkline, Biokangtai, Lanzhou Institute, Olymvax, Sanofi Pasteur, Walvax Biotechnology and Zhifei Biological, etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Haemophilus Influenzae Type b Conjugate Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Haemophilus Influenzae Type b Conjugate Vaccine.
The Haemophilus Influenzae Type b Conjugate Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Haemophilus Influenzae Type b Conjugate Vaccine market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Haemophilus Influenzae Type b Conjugate Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Bharat Biotech
Glaxosmithkline
Biokangtai
Lanzhou Institute
Olymvax
Sanofi Pasteur
Walvax Biotechnology
Zhifei Biological
Segment by Type
Vials
Prefilled
Segment by Application
Hospitals
Community Health Service Center
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Haemophilus Influenzae Type b Conjugate Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Haemophilus Influenzae Type b Conjugate Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Haemophilus Influenzae Type b Conjugate Vaccine Market Overview
1.1 Product Overview and Scope of Haemophilus Influenzae Type b Conjugate Vaccine
1.2 Haemophilus Influenzae Type b Conjugate Vaccine Segment by Type
1.2.1 Global Haemophilus Influenzae Type b Conjugate Vaccine Market Value Comparison by Type (2023-2029)
1.2.2 Vials
1.2.3 Prefilled
1.3 Haemophilus Influenzae Type b Conjugate Vaccine Segment by Application
1.3.1 Global Haemophilus Influenzae Type b Conjugate Vaccine Market Value by Application: (2023-2029)
1.3.2 Hospitals
1.3.3 Community Health Service Center
1.3.4 Others
1.4 Global Haemophilus Influenzae Type b Conjugate Vaccine Market Size Estimates and Forecasts
1.4.1 Global Haemophilus Influenzae Type b Conjugate Vaccine Revenue 2018-2029
1.4.2 Global Haemophilus Influenzae Type b Conjugate Vaccine Sales 2018-2029
1.4.3 Global Haemophilus Influenzae Type b Conjugate Vaccine Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Haemophilus Influenzae Type b Conjugate Vaccine Market Competition by Manufacturers
2.1 Global Haemophilus Influenzae Type b Conjugate Vaccine Sales Market Share by Manufacturers (2018-2023)
2.2 Global Haemophilus Influenzae Type b Conjugate Vaccine Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Haemophilus Influenzae Type b Conjugate Vaccine Average Price by Manufacturers (2018-2023)
2.4 Global Haemophilus Influenzae Type b Conjugate Vaccine Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Haemophilus Influenzae Type b Conjugate Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Haemophilus Influenzae Type b Conjugate Vaccine, Product Type & Application
2.7 Haemophilus Influenzae Type b Conjugate Vaccine Market Competitive Situation and Trends
2.7.1 Haemophilus Influenzae Type b Conjugate Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Haemophilus Influenzae Type b Conjugate Vaccine Players Market Share by Revenue
2.7.3 Global Haemophilus Influenzae Type b Conjugate Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Haemophilus Influenzae Type b Conjugate Vaccine Retrospective Market Scenario by Region
3.1 Global Haemophilus Influenzae Type b Conjugate Vaccine Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Haemophilus Influenzae Type b Conjugate Vaccine Global Haemophilus Influenzae Type b Conjugate Vaccine Sales by Region: 2018-2029
3.2.1 Global Haemophilus Influenzae Type b Conjugate Vaccine Sales by Region: 2018-2023
3.2.2 Global Haemophilus Influenzae Type b Conjugate Vaccine Sales by Region: 2024-2029
3.3 Global Haemophilus Influenzae Type b Conjugate Vaccine Global Haemophilus Influenzae Type b Conjugate Vaccine Revenue by Region: 2018-2029
3.3.1 Global Haemophilus Influenzae Type b Conjugate Vaccine Revenue by Region: 2018-2023
3.3.2 Global Haemophilus Influenzae Type b Conjugate Vaccine Revenue by Region: 2024-2029
3.4 North America Haemophilus Influenzae Type b Conjugate Vaccine Market Facts & Figures by Country
3.4.1 North America Haemophilus Influenzae Type b Conjugate Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Haemophilus Influenzae Type b Conjugate Vaccine Sales by Country (2018-2029)
3.4.3 North America Haemophilus Influenzae Type b Conjugate Vaccine Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Haemophilus Influenzae Type b Conjugate Vaccine Market Facts & Figures by Country
3.5.1 Europe Haemophilus Influenzae Type b Conjugate Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Haemophilus Influenzae Type b Conjugate Vaccine Sales by Country (2018-2029)
3.5.3 Europe Haemophilus Influenzae Type b Conjugate Vaccine Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Haemophilus Influenzae Type b Conjugate Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Haemophilus Influenzae Type b Conjugate Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Haemophilus Influenzae Type b Conjugate Vaccine Sales by Country (2018-2029)
3.6.3 Asia Pacific Haemophilus Influenzae Type b Conjugate Vaccine Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Haemophilus Influenzae Type b Conjugate Vaccine Market Facts & Figures by Country
3.7.1 Latin America Haemophilus Influenzae Type b Conjugate Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Haemophilus Influenzae Type b Conjugate Vaccine Sales by Country (2018-2029)
3.7.3 Latin America Haemophilus Influenzae Type b Conjugate Vaccine Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Haemophilus Influenzae Type b Conjugate Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Haemophilus Influenzae Type b Conjugate Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Haemophilus Influenzae Type b Conjugate Vaccine Sales by Country (2018-2029)
3.8.3 Middle East and Africa Haemophilus Influenzae Type b Conjugate Vaccine Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Haemophilus Influenzae Type b Conjugate Vaccine Sales by Type (2018-2029)
4.1.1 Global Haemophilus Influenzae Type b Conjugate Vaccine Sales by Type (2018-2023)
4.1.2 Global Haemophilus Influenzae Type b Conjugate Vaccine Sales by Type (2024-2029)
4.1.3 Global Haemophilus Influenzae Type b Conjugate Vaccine Sales Market Share by Type (2018-2029)
4.2 Global Haemophilus Influenzae Type b Conjugate Vaccine Revenue by Type (2018-2029)
4.2.1 Global Haemophilus Influenzae Type b Conjugate Vaccine Revenue by Type (2018-2023)
4.2.2 Global Haemophilus Influenzae Type b Conjugate Vaccine Revenue by Type (2024-2029)
4.2.3 Global Haemophilus Influenzae Type b Conjugate Vaccine Revenue Market Share by Type (2018-2029)
4.3 Global Haemophilus Influenzae Type b Conjugate Vaccine Price by Type (2018-2029)
5 Segment by Application
5.1 Global Haemophilus Influenzae Type b Conjugate Vaccine Sales by Application (2018-2029)
5.1.1 Global Haemophilus Influenzae Type b Conjugate Vaccine Sales by Application (2018-2023)
5.1.2 Global Haemophilus Influenzae Type b Conjugate Vaccine Sales by Application (2024-2029)
5.1.3 Global Haemophilus Influenzae Type b Conjugate Vaccine Sales Market Share by Application (2018-2029)
5.2 Global Haemophilus Influenzae Type b Conjugate Vaccine Revenue by Application (2018-2029)
5.2.1 Global Haemophilus Influenzae Type b Conjugate Vaccine Revenue by Application (2018-2023)
5.2.2 Global Haemophilus Influenzae Type b Conjugate Vaccine Revenue by Application (2024-2029)
5.2.3 Global Haemophilus Influenzae Type b Conjugate Vaccine Revenue Market Share by Application (2018-2029)
5.3 Global Haemophilus Influenzae Type b Conjugate Vaccine Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Bharat Biotech
6.1.1 Bharat Biotech Corporation Information
6.1.2 Bharat Biotech Description and Business Overview
6.1.3 Bharat Biotech Haemophilus Influenzae Type b Conjugate Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Bharat Biotech Haemophilus Influenzae Type b Conjugate Vaccine Product Portfolio
6.1.5 Bharat Biotech Recent Developments/Updates
6.2 Glaxosmithkline
6.2.1 Glaxosmithkline Corporation Information
6.2.2 Glaxosmithkline Description and Business Overview
6.2.3 Glaxosmithkline Haemophilus Influenzae Type b Conjugate Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Glaxosmithkline Haemophilus Influenzae Type b Conjugate Vaccine Product Portfolio
6.2.5 Glaxosmithkline Recent Developments/Updates
6.3 Biokangtai
6.3.1 Biokangtai Corporation Information
6.3.2 Biokangtai Description and Business Overview
6.3.3 Biokangtai Haemophilus Influenzae Type b Conjugate Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Biokangtai Haemophilus Influenzae Type b Conjugate Vaccine Product Portfolio
6.3.5 Biokangtai Recent Developments/Updates
6.4 Lanzhou Institute
6.4.1 Lanzhou Institute Corporation Information
6.4.2 Lanzhou Institute Description and Business Overview
6.4.3 Lanzhou Institute Haemophilus Influenzae Type b Conjugate Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Lanzhou Institute Haemophilus Influenzae Type b Conjugate Vaccine Product Portfolio
6.4.5 Lanzhou Institute Recent Developments/Updates
6.5 Olymvax
6.5.1 Olymvax Corporation Information
6.5.2 Olymvax Description and Business Overview
6.5.3 Olymvax Haemophilus Influenzae Type b Conjugate Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Olymvax Haemophilus Influenzae Type b Conjugate Vaccine Product Portfolio
6.5.5 Olymvax Recent Developments/Updates
6.6 Sanofi Pasteur
6.6.1 Sanofi Pasteur Corporation Information
6.6.2 Sanofi Pasteur Description and Business Overview
6.6.3 Sanofi Pasteur Haemophilus Influenzae Type b Conjugate Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Sanofi Pasteur Haemophilus Influenzae Type b Conjugate Vaccine Product Portfolio
6.6.5 Sanofi Pasteur Recent Developments/Updates
6.7 Walvax Biotechnology
6.6.1 Walvax Biotechnology Corporation Information
6.6.2 Walvax Biotechnology Description and Business Overview
6.6.3 Walvax Biotechnology Haemophilus Influenzae Type b Conjugate Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Walvax Biotechnology Haemophilus Influenzae Type b Conjugate Vaccine Product Portfolio
6.7.5 Walvax Biotechnology Recent Developments/Updates
6.8 Zhifei Biological
6.8.1 Zhifei Biological Corporation Information
6.8.2 Zhifei Biological Description and Business Overview
6.8.3 Zhifei Biological Haemophilus Influenzae Type b Conjugate Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Zhifei Biological Haemophilus Influenzae Type b Conjugate Vaccine Product Portfolio
6.8.5 Zhifei Biological Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Haemophilus Influenzae Type b Conjugate Vaccine Industry Chain Analysis
7.2 Haemophilus Influenzae Type b Conjugate Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Haemophilus Influenzae Type b Conjugate Vaccine Production Mode & Process
7.4 Haemophilus Influenzae Type b Conjugate Vaccine Sales and Marketing
7.4.1 Haemophilus Influenzae Type b Conjugate Vaccine Sales Channels
7.4.2 Haemophilus Influenzae Type b Conjugate Vaccine Distributors
7.5 Haemophilus Influenzae Type b Conjugate Vaccine Customers
8 Haemophilus Influenzae Type b Conjugate Vaccine Market Dynamics
8.1 Haemophilus Influenzae Type b Conjugate Vaccine Industry Trends
8.2 Haemophilus Influenzae Type b Conjugate Vaccine Market Drivers
8.3 Haemophilus Influenzae Type b Conjugate Vaccine Market Challenges
8.4 Haemophilus Influenzae Type b Conjugate Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Tables
Table 1. Global Haemophilus Influenzae Type b Conjugate Vaccine Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Haemophilus Influenzae Type b Conjugate Vaccine Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Haemophilus Influenzae Type b Conjugate Vaccine Market Competitive Situation by Manufacturers in 2022
Table 4. Global Haemophilus Influenzae Type b Conjugate Vaccine Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Haemophilus Influenzae Type b Conjugate Vaccine Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Haemophilus Influenzae Type b Conjugate Vaccine Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Haemophilus Influenzae Type b Conjugate Vaccine Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Haemophilus Influenzae Type b Conjugate Vaccine Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Haemophilus Influenzae Type b Conjugate Vaccine, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Haemophilus Influenzae Type b Conjugate Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Haemophilus Influenzae Type b Conjugate Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of Haemophilus Influenzae Type b Conjugate Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Haemophilus Influenzae Type b Conjugate Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Haemophilus Influenzae Type b Conjugate Vaccine as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Haemophilus Influenzae Type b Conjugate Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Haemophilus Influenzae Type b Conjugate Vaccine Sales by Region (2018-2023) & (K Units)
Table 18. Global Haemophilus Influenzae Type b Conjugate Vaccine Sales Market Share by Region (2018-2023)
Table 19. Global Haemophilus Influenzae Type b Conjugate Vaccine Sales by Region (2024-2029) & (K Units)
Table 20. Global Haemophilus Influenzae Type b Conjugate Vaccine Sales Market Share by Region (2024-2029)
Table 21. Global Haemophilus Influenzae Type b Conjugate Vaccine Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Haemophilus Influenzae Type b Conjugate Vaccine Revenue Market Share by Region (2018-2023)
Table 23. Global Haemophilus Influenzae Type b Conjugate Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Haemophilus Influenzae Type b Conjugate Vaccine Revenue Market Share by Region (2024-2029)
Table 25. North America Haemophilus Influenzae Type b Conjugate Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Haemophilus Influenzae Type b Conjugate Vaccine Sales by Country (2018-2023) & (K Units)
Table 27. North America Haemophilus Influenzae Type b Conjugate Vaccine Sales by Country (2024-2029) & (K Units)
Table 28. North America Haemophilus Influenzae Type b Conjugate Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Haemophilus Influenzae Type b Conjugate Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Haemophilus Influenzae Type b Conjugate Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Haemophilus Influenzae Type b Conjugate Vaccine Sales by Country (2018-2023) & (K Units)
Table 32. Europe Haemophilus Influenzae Type b Conjugate Vaccine Sales by Country (2024-2029) & (K Units)
Table 33. Europe Haemophilus Influenzae Type b Conjugate Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Haemophilus Influenzae Type b Conjugate Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Haemophilus Influenzae Type b Conjugate Vaccine Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Haemophilus Influenzae Type b Conjugate Vaccine Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Haemophilus Influenzae Type b Conjugate Vaccine Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Haemophilus Influenzae Type b Conjugate Vaccine Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Haemophilus Influenzae Type b Conjugate Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Haemophilus Influenzae Type b Conjugate Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Haemophilus Influenzae Type b Conjugate Vaccine Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Haemophilus Influenzae Type b Conjugate Vaccine Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Haemophilus Influenzae Type b Conjugate Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Haemophilus Influenzae Type b Conjugate Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Haemophilus Influenzae Type b Conjugate Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Haemophilus Influenzae Type b Conjugate Vaccine Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Haemophilus Influenzae Type b Conjugate Vaccine Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Haemophilus Influenzae Type b Conjugate Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Haemophilus Influenzae Type b Conjugate Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Haemophilus Influenzae Type b Conjugate Vaccine Sales (K Units) by Type (2018-2023)
Table 51. Global Haemophilus Influenzae Type b Conjugate Vaccine Sales (K Units) by Type (2024-2029)
Table 52. Global Haemophilus Influenzae Type b Conjugate Vaccine Sales Market Share by Type (2018-2023)
Table 53. Global Haemophilus Influenzae Type b Conjugate Vaccine Sales Market Share by Type (2024-2029)
Table 54. Global Haemophilus Influenzae Type b Conjugate Vaccine Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Haemophilus Influenzae Type b Conjugate Vaccine Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Haemophilus Influenzae Type b Conjugate Vaccine Revenue Market Share by Type (2018-2023)
Table 57. Global Haemophilus Influenzae Type b Conjugate Vaccine Revenue Market Share by Type (2024-2029)
Table 58. Global Haemophilus Influenzae Type b Conjugate Vaccine Price (US$/Unit) by Type (2018-2023)
Table 59. Global Haemophilus Influenzae Type b Conjugate Vaccine Price (US$/Unit) by Type (2024-2029)
Table 60. Global Haemophilus Influenzae Type b Conjugate Vaccine Sales (K Units) by Application (2018-2023)
Table 61. Global Haemophilus Influenzae Type b Conjugate Vaccine Sales (K Units) by Application (2024-2029)
Table 62. Global Haemophilus Influenzae Type b Conjugate Vaccine Sales Market Share by Application (2018-2023)
Table 63. Global Haemophilus Influenzae Type b Conjugate Vaccine Sales Market Share by Application (2024-2029)
Table 64. Global Haemophilus Influenzae Type b Conjugate Vaccine Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Haemophilus Influenzae Type b Conjugate Vaccine Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Haemophilus Influenzae Type b Conjugate Vaccine Revenue Market Share by Application (2018-2023)
Table 67. Global Haemophilus Influenzae Type b Conjugate Vaccine Revenue Market Share by Application (2024-2029)
Table 68. Global Haemophilus Influenzae Type b Conjugate Vaccine Price (US$/Unit) by Application (2018-2023)
Table 69. Global Haemophilus Influenzae Type b Conjugate Vaccine Price (US$/Unit) by Application (2024-2029)
Table 70. Bharat Biotech Corporation Information
Table 71. Bharat Biotech Description and Business Overview
Table 72. Bharat Biotech Haemophilus Influenzae Type b Conjugate Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. Bharat Biotech Haemophilus Influenzae Type b Conjugate Vaccine Product
Table 74. Bharat Biotech Recent Developments/Updates
Table 75. Glaxosmithkline Corporation Information
Table 76. Glaxosmithkline Description and Business Overview
Table 77. Glaxosmithkline Haemophilus Influenzae Type b Conjugate Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. Glaxosmithkline Haemophilus Influenzae Type b Conjugate Vaccine Product
Table 79. Glaxosmithkline Recent Developments/Updates
Table 80. Biokangtai Corporation Information
Table 81. Biokangtai Description and Business Overview
Table 82. Biokangtai Haemophilus Influenzae Type b Conjugate Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Biokangtai Haemophilus Influenzae Type b Conjugate Vaccine Product
Table 84. Biokangtai Recent Developments/Updates
Table 85. Lanzhou Institute Corporation Information
Table 86. Lanzhou Institute Description and Business Overview
Table 87. Lanzhou Institute Haemophilus Influenzae Type b Conjugate Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Lanzhou Institute Haemophilus Influenzae Type b Conjugate Vaccine Product
Table 89. Lanzhou Institute Recent Developments/Updates
Table 90. Olymvax Corporation Information
Table 91. Olymvax Description and Business Overview
Table 92. Olymvax Haemophilus Influenzae Type b Conjugate Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Olymvax Haemophilus Influenzae Type b Conjugate Vaccine Product
Table 94. Olymvax Recent Developments/Updates
Table 95. Sanofi Pasteur Corporation Information
Table 96. Sanofi Pasteur Description and Business Overview
Table 97. Sanofi Pasteur Haemophilus Influenzae Type b Conjugate Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Sanofi Pasteur Haemophilus Influenzae Type b Conjugate Vaccine Product
Table 99. Sanofi Pasteur Recent Developments/Updates
Table 100. Walvax Biotechnology Corporation Information
Table 101. Walvax Biotechnology Description and Business Overview
Table 102. Walvax Biotechnology Haemophilus Influenzae Type b Conjugate Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Walvax Biotechnology Haemophilus Influenzae Type b Conjugate Vaccine Product
Table 104. Walvax Biotechnology Recent Developments/Updates
Table 105. Zhifei Biological Corporation Information
Table 106. Zhifei Biological Description and Business Overview
Table 107. Zhifei Biological Haemophilus Influenzae Type b Conjugate Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Zhifei Biological Haemophilus Influenzae Type b Conjugate Vaccine Product
Table 109. Zhifei Biological Recent Developments/Updates
Table 110. Key Raw Materials Lists
Table 111. Raw Materials Key Suppliers Lists
Table 112. Haemophilus Influenzae Type b Conjugate Vaccine Distributors List
Table 113. Haemophilus Influenzae Type b Conjugate Vaccine Customers List
Table 114. Haemophilus Influenzae Type b Conjugate Vaccine Market Trends
Table 115. Haemophilus Influenzae Type b Conjugate Vaccine Market Drivers
Table 116. Haemophilus Influenzae Type b Conjugate Vaccine Market Challenges
Table 117. Haemophilus Influenzae Type b Conjugate Vaccine Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Haemophilus Influenzae Type b Conjugate Vaccine
Figure 2. Global Haemophilus Influenzae Type b Conjugate Vaccine Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Haemophilus Influenzae Type b Conjugate Vaccine Market Share by Type in 2022 & 2029
Figure 4. Vials Product Picture
Figure 5. Prefilled Product Picture
Figure 6. Global Haemophilus Influenzae Type b Conjugate Vaccine Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Haemophilus Influenzae Type b Conjugate Vaccine Market Share by Application in 2022 & 2029
Figure 8. Hospitals
Figure 9. Community Health Service Center
Figure 10. Others
Figure 11. Global Haemophilus Influenzae Type b Conjugate Vaccine Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Haemophilus Influenzae Type b Conjugate Vaccine Market Size (2018-2029) & (US$ Million)
Figure 13. Global Haemophilus Influenzae Type b Conjugate Vaccine Sales (2018-2029) & (K Units)
Figure 14. Global Haemophilus Influenzae Type b Conjugate Vaccine Average Price (US$/Unit) & (2018-2029)
Figure 15. Haemophilus Influenzae Type b Conjugate Vaccine Report Years Considered
Figure 16. Haemophilus Influenzae Type b Conjugate Vaccine Sales Share by Manufacturers in 2022
Figure 17. Global Haemophilus Influenzae Type b Conjugate Vaccine Revenue Share by Manufacturers in 2022
Figure 18. The Global 5 and 10 Largest Haemophilus Influenzae Type b Conjugate Vaccine Players: Market Share by Revenue in 2022
Figure 19. Haemophilus Influenzae Type b Conjugate Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 20. Global Haemophilus Influenzae Type b Conjugate Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 21. North America Haemophilus Influenzae Type b Conjugate Vaccine Sales Market Share by Country (2018-2029)
Figure 22. North America Haemophilus Influenzae Type b Conjugate Vaccine Revenue Market Share by Country (2018-2029)
Figure 23. U.S. Haemophilus Influenzae Type b Conjugate Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Canada Haemophilus Influenzae Type b Conjugate Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Europe Haemophilus Influenzae Type b Conjugate Vaccine Sales Market Share by Country (2018-2029)
Figure 26. Europe Haemophilus Influenzae Type b Conjugate Vaccine Revenue Market Share by Country (2018-2029)
Figure 27. Germany Haemophilus Influenzae Type b Conjugate Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. France Haemophilus Influenzae Type b Conjugate Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. U.K. Haemophilus Influenzae Type b Conjugate Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Italy Haemophilus Influenzae Type b Conjugate Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Russia Haemophilus Influenzae Type b Conjugate Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Asia Pacific Haemophilus Influenzae Type b Conjugate Vaccine Sales Market Share by Region (2018-2029)
Figure 33. Asia Pacific Haemophilus Influenzae Type b Conjugate Vaccine Revenue Market Share by Region (2018-2029)
Figure 34. China Haemophilus Influenzae Type b Conjugate Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Japan Haemophilus Influenzae Type b Conjugate Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. South Korea Haemophilus Influenzae Type b Conjugate Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. India Haemophilus Influenzae Type b Conjugate Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Australia Haemophilus Influenzae Type b Conjugate Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Taiwan Haemophilus Influenzae Type b Conjugate Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Indonesia Haemophilus Influenzae Type b Conjugate Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Thailand Haemophilus Influenzae Type b Conjugate Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Malaysia Haemophilus Influenzae Type b Conjugate Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Philippines Haemophilus Influenzae Type b Conjugate Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Latin America Haemophilus Influenzae Type b Conjugate Vaccine Sales Market Share by Country (2018-2029)
Figure 45. Latin America Haemophilus Influenzae Type b Conjugate Vaccine Revenue Market Share by Country (2018-2029)
Figure 46. Mexico Haemophilus Influenzae Type b Conjugate Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Brazil Haemophilus Influenzae Type b Conjugate Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Argentina Haemophilus Influenzae Type b Conjugate Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Middle East & Africa Haemophilus Influenzae Type b Conjugate Vaccine Sales Market Share by Country (2018-2029)
Figure 50. Middle East & Africa Haemophilus Influenzae Type b Conjugate Vaccine Revenue Market Share by Country (2018-2029)
Figure 51. Turkey Haemophilus Influenzae Type b Conjugate Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Saudi Arabia Haemophilus Influenzae Type b Conjugate Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. U.A.E Haemophilus Influenzae Type b Conjugate Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. Global Sales Market Share of Haemophilus Influenzae Type b Conjugate Vaccine by Type (2018-2029)
Figure 55. Global Revenue Market Share of Haemophilus Influenzae Type b Conjugate Vaccine by Type (2018-2029)
Figure 56. Global Haemophilus Influenzae Type b Conjugate Vaccine Price (US$/Unit) by Type (2018-2029)
Figure 57. Global Sales Market Share of Haemophilus Influenzae Type b Conjugate Vaccine by Application (2018-2029)
Figure 58. Global Revenue Market Share of Haemophilus Influenzae Type b Conjugate Vaccine by Application (2018-2029)
Figure 59. Global Haemophilus Influenzae Type b Conjugate Vaccine Price (US$/Unit) by Application (2018-2029)
Figure 60. Haemophilus Influenzae Type b Conjugate Vaccine Value Chain
Figure 61. Haemophilus Influenzae Type b Conjugate Vaccine Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 13価肺炎球菌多糖体複合体ワクチンのグローバル市場展望 2023年-2029年：バイアル、充填済み
  • プロトロンビン複合体濃縮物（PCC）医薬品の世界市場2023年：500 IU/バイアル、600 IU/バイアル、1000 IU/バイアル、その他
  • チオテパ注射のグローバル市場展望 2023年-2029年：15mg/バイアル、100mg/バイアル
  • 細胞培養系インフルエンザワクチンのグローバル市場展望 2023年-2029年：バイアル、充填済み
  • セービン不活化ポリオワクチン（sIPV）の世界市場2023年：バイアル、シリンジ
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA8781 )"インフルエンザ菌b型混合ワクチンの世界市場2023年：バイアル、プレフィルド" (英文：Global Haemophilus Influenzae Type b Conjugate Vaccine Market Research Report 2023)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。